glenmark-life-sciences-ltd
Home
Glenmark Life Sciences Ltd
GLS Share Price
BSE:
NSE:GLS
GLS Share Price
BSE:
NSE:GLS
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹12,823.68 Cr
PE Ratio
30.28
Glenmark Life Sciences Ltd Performance
▲
▲
▲
▲
Glenmark Life Sciences Ltd Fundamentals
Glenmark Life Sciences Ltd Delivery and Volume
About Glenmark Life Sciences Ltd
Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Sh
| Name | Designation |
|---|---|
| Yasir Yusufali Rawjee | Managing Director & CEO |
| Vinod Naik | Executive Director |
| Manju Agarwal | Independent Non Exe. Director |
| Taruvai Laxminarayanan Easwar | Independent Non Exe. Director |
| HIREN KARSANBHAI PATEL | Chairman (Non-Executive) |
| KAUSHIKBHAI NANDUBHAI PATEL | Independent Director |
| VIJAYKUMAR RATILAL SHAH | Independent Director |
| Savan Godialwala | Independent Director |
| Rudalf Corriea | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Glenmark Life Sciences Ltd FAQs
How do I Buy Glenmark Life Sciences Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Glenmark Life Sciences Ltd shares in BlinkX.
What is the Share Price of Glenmark Life Sciences Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Glenmark Life Sciences Ltd's share price is ₹1049.85 as of 2024-12-11.
What is the PE ratio of Glenmark Life Sciences Ltd?
Glenmark Life Sciences Ltd's P/E ratio is 30.28 times as of 2024-12-11.
What is the PB ratio of Glenmark Life Sciences Ltd?
Glenmark Life Sciences Ltd's most recent financial reports indicate a price-to-book ratio of 5.05, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Glenmark Life Sciences Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Glenmark Life Sciences Ltd's market capitalization is ₹12823.68 Cr as on 2024-12-11.
What is the ROE of Glenmark Life Sciences Ltd?
The current financial records of Glenmark Life Sciences Ltd show a 21.07% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Glenmark Life Sciences Ltd?
According to Glenmark Life Sciences Ltd's most recent financial filings, the company has a total asset value of ₹1920.55, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Glenmark Life Sciences Ltd?
The 52-week high/low price of a Glenmark Life Sciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Glenmark Life Sciences Ltd's 52-week high and low as of 2024-12-11 are ₹1055 and ₹1024, respectively.
